
浏览全部资源
扫码关注微信
400037 重庆,陆军军医大学(第三军医大学)第二附属医院神经内科
[ 杨清武,博士,主任医师,教授,博士研究生导师,陆军军医大学第二附属医院神经医学中心主任。教育部“长江学者”特聘教授,国家万人计划科技创新领军人才,全军高层次创新人才工程拔尖人才,国务院特殊津贴获得者。担任中华医学会神经病学分会委员,重庆市卒中学会会长。主持国家自然科学基金重大项目、国家自然科学基金重点项目、国家杰出青年科学基金、国家973课题、军队重大研究课题等20余项。培养博士后、博士、硕士研究生50余名。担任Translation Stroke Research、Frontier in Neuroscience、Stroke Vascular Neurology等杂志副主编和编委。以通信作者在JAMA、JAMA Neurol、Ann Neurol、Prog Neurobiol、Circulation、Stroke、J Immunol、JCBFM等SCI收录期刊发表论文60余篇。主要从事急性脑血管病防治的基础与临床转化方面的研究。E-mail: yangqwmlys@163.com YANG Qingwu, E-mail: yangqwmlys@163.com
资文杰, 博士后, 副主任医师, 主要从事缺血性脑卒中的基础与临床方面的研究。E-mail: ziwenjie1981@163.com
收稿:2021-04-22,
修回:2021-05-16,
纸质出版:2021-07-30
移动端阅览
杨清武, 资文杰. 急性颅内大血管闭塞血运重建: 直接还是桥接取栓?——研究回顾及展望[J]. 第三军医大学学报, 2021,43(14):1299-1303.
Qingwu YANG, Wenjie ZI. Revascularization in acute intracranial large vessels occlusion: direct or bridging thrombectomy?[J]. Journal of Third Military Medical University, 2021, 43(14): 1299-1303.
杨清武, 资文杰. 急性颅内大血管闭塞血运重建: 直接还是桥接取栓?——研究回顾及展望[J]. 第三军医大学学报, 2021,43(14):1299-1303. DOI: 10.16016/j.1000-5404.202104153.
Qingwu YANG, Wenjie ZI. Revascularization in acute intracranial large vessels occlusion: direct or bridging thrombectomy?[J]. Journal of Third Military Medical University, 2021, 43(14): 1299-1303. DOI: 10.16016/j.1000-5404.202104153.
急性缺血性卒中早期管理指南推荐静脉溶栓桥接血管内治疗作为发病4.5 h内急性大血管闭塞致缺血性卒中的首选治疗方法。然而,血管内治疗前的阿替普酶静脉溶栓治疗是一把双刃剑,既可带来获益也可增加风险。是否可以跨过静脉溶栓,直接进行血管内治疗是目前卒中领域研究的焦点。已结束的4项针对发病4.5 h内急性大血管闭塞比较直接血管内治疗与静脉溶栓桥接血管内治疗有效性及安全性的多中心随机对照试验结果表明,直接血管内治疗组功能独立比例与静脉溶栓桥接血管内治疗组接近,两种治疗策略的症状性脑出血发生率及病死率差异无统计学意义。直接血管内治疗可能作为发病4.5 h内急性颅内大血管闭塞患者的新选择。
Guidelines for the early management of acute ischemic stroke recommend intravenous thrombolysis followed by endovascular treatment as the first choice for the treatment of stroke with large vessel occlusion within 4.5 h of symptom onset. However
intravenous thrombolysis before endovascular treatment is a double-edged sword
which can not only bring benefits
but also increase risks. Currently
whether it is reasonable to omit intravenous thrombolysis and directly perform endovascular treatment is one of the most controversial issue. Four randomized
controlled
multicenter trial of direct endovascular treatment versus standard bridging therapy for acute stroke patients with large vessel occlusion in the anterior circulation demonstrated that the functional independence rate of the direct endovascular treatment group is similar to that of the intravenous thrombolysis followed by endovascular treatment group
and no significant difference was observed in the incidence of symptomatic intracerebral hemorrhage and mortality between the 2 treatment groups. Direct endovascular treatment may be used as a new option for patients with acute large vessel occlusion within 4.5 h of stroke onset.
National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke[J]. N Engl J Med, 1995, 333(24): 1581-1587. DOI:10.1056/NEJM199512143332401.
BERKHEMER O A, FRANSEN P S, BEUMER D, et al . A randomized trial of intraarterial treatment for acute ischemic stroke[J ] . N Engl J Med, 2015, 372(1): 11-20. DOI:10.1056/NEJMoa1411587.
JOVIN T G, CHAMORRO A, COBO E, et al . Thrombectomy within 8 hours after symptom onset in ischemic stroke[J ] . N Engl J Med, 2015, 372(24): 2296-2306. DOI:10.1056/NEJMoa1503780.
SAVER J L, G OYAL M, BONAFE A, et al . Stent-retriever thrombectomy after intravenous t-PA vs . t-PA alone in stroke[J ] . N Engl J Med, 2015, 372(24): 2285-2295. DOI:10.1056/NEJMoa1415061..
GOYAL M, MENON B K, VAN ZWAM W H, et al . Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials[J ] . Lancet, 2016, 387(10029): 1723-1731. DOI:10.1016/S0140-6736(16)00163-X.
BHATIA R, HILL M D, SHOBHA N, et al . Low rates of acute recanalization with intravenous recombinant tissue plasminogen activator inischemic stroke: Real-world experience and a call for action[J ] . Stroke, 2010, 41(10): 2254-2258. DOI:10.1161/STROKEAHA.110.592535.
CHANDRA R V, LESLIE-MAZWI T M, MEHTA B P, et al . Does the use of Ⅳ tPA in the current era of rapid and predictable recanalization by mechanical embolectomy represent good value?[J ] . J Neurointerv Surg, 2016, 8(5): 443-446. DOI:10.1136/neurintsurg-2015-012231.
REN Y F, CHURILOV L, MITCHELL P, et al . Clot migration is associated with intravenous thrombolysis in the setting of acute ischemic stroke[J ] . Stroke, 2018, 49(12): 3060-3062. DOI:10.1161/STROKEAHA.118.022751.
RAI A T, BOO S, BUSEMAN C, et al . Intravenous thrombolysis before endovascular therapy for large vessel strokes can lead to significantly higher hospital costs without improving outcomes[J ] . J Neurointerv Surg, 2018, 10(1): 17-21. DOI:10.1136/neurintsurg-2016-012830.
中华医学会神经病学分会, 中华医学会神经病学分会脑血管病学组, 中华医学会神经病学分会神经血管介入协作组. 中国急性缺血性脑卒中早期血管内介入诊疗指南2018[J]. 中华神经科杂志, 2018, 51 (9): 683-691. DOI:10.3760/cma.j.issn.1006-7876.2018.09.005.
Branch of Neurology of Chinese Medical Association, Cerebrovascular Disease Group of Branch of Neurology of Chinese Medical Association, Neuro-intervention Group of Chinese Medical Association. Chinese guidelines for the endovascular treatment of acute ischemic stroke 2018[J]. Chin J Neurol, 2018, 51 (9): 683-691. DOI:10.3760/cma.j.issn.1006-7876.2018.09.005.
POWERS W J, RABINSTEIN A A, ACKERSON T, et al . 2018 guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American heart association/American stroke association[J ] . Stroke, 2018, 49(3): e46-e110. DOI:10.1161/STR.0000000000000158.
ZI W, QIU Z, LI F, et al . Effect of endovascular treatment alone vs intravenous alteplase plus endovascular treatment on functional independence in patients with acute ischemic stroke: the DEVT randomized clinical trial[J ] . JAMA, 2021, 325(3): 234-243. DOI:10.1001/jama.2020.23523.
YANG P, ZHANG Y, ZHANG L, et al . Endovascular thrombectomy with or without intravenous alteplase in acute stroke[J ] . N Engl J Med, 2020, 382(21): 1981-1993. DOI:10.1056/NEJMoa2001123.
SUZUKI K, MATSUMARU Y, TAKEUCHI M, et al . Effect of mechanical thrombectomy without vs with intravenous thrombolysis on functional outcome among patients with acute ischemic stroke: The skip randomized clinical trial[J ] . JAMA, 2021, 325(3): 244-253. DOI:10.1001/jama.2020.23522..
TREURNIET K M, LECOUFFE N E, KAPPELHOF M, et al . Mr clean-no iv: Intravenous treatment followed by endovascular treatment versus direct endovascular treatment for acute ischemic stroke caused by a proximal intracranial occlusion-study protocol for a randomized clinical trial[J ] . Trials, 2021, 22(1): 141. DOI:10.1186/s13063-021-05063-5.
LIN C J, SAVER J L. Noninferiority margins in trials of thrombectomy devices for acute ischemic stroke: is the bar being set too low?[J]. Stroke, 2019, 50(12): 3519-3526. DOI:10.1161/STROKEAHA.119.026717.
GERSCHENFELD G, MURESAN I P, BLANC R, et al . Two paradigms for endovascular thrombectomy after intravenous thrombolysis for acute ischemic stroke[J ] . JAMA Neurol, 2017, 74(5): 549-556. DOI:10.1001/jamaneurol.2016.5823.
CAMPBELL B C V, MITCHELL P J, CHURILOV L, et al . Tenecteplase versus alteplase before thrombectomy for ischemic stroke[J ] . N Engl J Med, 2018, 378(17): 1573-1582. DOI:10.1056/NEJMoa1716405.
0
浏览量
0
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621